mevalonic acid has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehpour, AR; Khoshbin, K; Saeedi Saravi, SS | 1 |
| Khasnavis, S; Pahan, K | 1 |
| Brahmachari, S; Gendelman, HE; Ghosh, A; Jana, A; Liu, X; Pahan, K; Roy, A | 1 |
1 review(s) available for mevalonic acid and Parkinson Disease
| Article | Year |
|---|---|
Current insights into pathogenesis of Parkinson's disease: Approach to mevalonate pathway and protective role of statins.
Topics: Animals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Neurons; Neuroprotective Agents; Parkinson Disease; Signal Transduction | 2017 |
2 other study(ies) available for mevalonic acid and Parkinson Disease
| Article | Year |
|---|---|
Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons.
Topics: Alkyl and Aryl Transferases; Animals; Astrocytes; Cinnamomum zeylanicum; Food Additives; Humans; Intracellular Signaling Peptides and Proteins; Mevalonic Acid; Mice; Neurons; Neuroprotective Agents; Oncogene Proteins; Parkinson Disease; Protein Deglycase DJ-1; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sodium Benzoate; Up-Regulation | 2012 |
Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease.
Topics: Animals; Antioxidants; Cytokines; Disease Models, Animal; Disease Progression; Dopaminergic Neurons; Enzyme Activation; Gene Expression Regulation; Humans; Inflammation Mediators; Male; Mevalonic Acid; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; Neuroglia; NF-kappa B; Nitric Oxide Synthase Type II; Oncogene Protein p21(ras); Parkinson Disease; Phenylbutyrates; Reactive Oxygen Species | 2012 |